End-of-day quote
Shanghai S.E.
07:00:00 2024-03-26 pm EDT
5-day change
1st Jan Change
6.1
CNY
-1.93%
-5.28%
-12.98%
Shanghai Cai Tongde Pharmaceutical Co., Ltd. announced that it has received CNY 20 million in funding from Shanghai New World Co., Ltd
On August 18, 2021, Shanghai Cai Tongde Pharmaceutical Co., Ltd. closed the transaction.
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-30
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-30
CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-28
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
23-04-12
CI
Shanghai New World Co., Ltd completed the acquisition of 6.1245% of stake in Zhejiang Guojun Co., Ltd. from Shen Guojun and Shen Junyan
23-03-06
CI
Shanghai New World Co., Ltd agreed to acquire 6.1245% of stake in Zhejiang Guojun Co., Ltd. from Shen Guojun and Shen Junyan for approximately CNY 490 million.
23-02-17
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-27
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-30
CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-29
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
21-10-28
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
21-08-26
CI
Shanghai Cai Tongde Pharmaceutical Co., Ltd. announced that it has received CNY 20 million in funding from Shanghai New World Co., Ltd
21-08-17
CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021
21-04-29
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020
21-04-14
CI
Shanghai Cai Tongde Pharmaceutical Co., Ltd. announced that it expects to receive CNY 20 million in funding from Shanghai New World Co., Ltd
21-01-17
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020
20-10-29
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020
20-08-27
CI
Shanghai New World Co., Ltd Announces Cash Dividend on A Share for the Year 2019, Payable on August 21, 2020
20-08-15
CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2020
20-04-29
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2019
20-04-16
CI
Shanghai New World Co., Ltd Announces Earnings Guidance for 2019
20-01-20
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2019
19-10-30
CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2019
19-08-27
CI
Shanghai New World Co., Ltd Announces Cash Dividend for the Year 2018, Payable on August 23, 2019
19-08-17
CI
Shanghai New World Co., Ltd. Provides Earnings Guidance for the First Half of 2019
19-07-22
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Shanghai New World Co Ltd is a China-based company mainly engaged in department store retail enterprises integrating modern department stores, tourism, leisure and entertainment comprehensive consumption. The Company operates its businesses through four segments. The Commercial segment is principally engaged in department store retail. The Pharmaceutical Industry segment is mainly engaged in the sales of various types of chinese medicinal materials, chinese patent medicines, western medicines, ginseng and antler supplements, nutritional health products and medical equipment. The Hotel Services segment is principally engaged in the operation of Radisson brand hotels managed by Radisson Hotel Group. The Company is also engaged in other businesses segment. The Company mainly operates its businesses in the domestic market.
More about the company
1st Jan change
Capi.
-12.98% 546M +33.50% 701B +26.24% 571B +0.78% 381B +20.85% 334B +16.38% 319B +2.77% 210B +1.04% 210B -6.73% 201B -3.51% 157B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1